These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27106773)

  • 1. Placental aging and oxidation damage in a tissue micro-array model: an immunohistochemistry study.
    Londero AP; Orsaria M; Marzinotto S; Grassi T; Fruscalzo A; Calcagno A; Bertozzi S; Nardini N; Stella E; Lellé RJ; Driul L; Tell G; Mariuzzi L
    Histochem Cell Biol; 2016 Aug; 146(2):191-204. PubMed ID: 27106773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome.
    Stepan H; Leo C; Purz S; Höckel M; Horn LC
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):172-6. PubMed ID: 16219518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction.
    Takagi Y; Nikaido T; Toki T; Kita N; Kanai M; Ashida T; Ohira S; Konishi I
    Virchows Arch; 2004 Jan; 444(1):49-55. PubMed ID: 14574573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome.
    Fruscalzo A; Schmitz R; Klockenbusch W; Köhler G; Londero AP; Siwetz M; Huppertz B
    Histochem Cell Biol; 2012 Dec; 138(6):925-32. PubMed ID: 22847813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental fibronectin staining is unaffected in pregnancies complicated by late-onset intrauterine growth restriction and small for gestational age fetuses.
    Fruscalzo A; Londero AP; Orsaria M; Marzinotto S; Driul L; Di Loreto C; Mariuzzi L
    Int J Gynaecol Obstet; 2020 Feb; 148(2):253-260. PubMed ID: 31743426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCN3 Signaling Is Differently Regulated in Placental Diseases Preeclampsia and Abnormally Invasive Placenta.
    Duan L; Schimmelmann M; Wu Y; Reisch B; Faas M; Kimmig R; Winterhager E; Köninger A; Gellhaus A
    Front Endocrinol (Lausanne); 2020; 11():597549. PubMed ID: 33304321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired cytotrophoblast cell-cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction.
    Langbein M; Strick R; Strissel PL; Vogt N; Parsch H; Beckmann MW; Schild RL
    Mol Reprod Dev; 2008 Jan; 75(1):175-83. PubMed ID: 17546632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of Base Excision Repair at the Maternal-Fetal Interface in Pregnancies Complicated by Preeclampsia.
    Tadesse S; Norwitz NG; Guller S; Arcuri F; Toti P; Norwitz ER; Kidane D
    Reprod Sci; 2017 Jun; 24(6):856-864. PubMed ID: 27707956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PP141. The lipid transporters ABCA1 and ABCG1 are differentially expressed in preeclamptic and IUGR placentas.
    Körner M; Wenger F; Nikitina L; Baumann M; Surbek D; Albrecht C
    Pregnancy Hypertens; 2012 Jul; 2(3):315-6. PubMed ID: 26105462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia.
    Mandò C; De Palma C; Stampalija T; Anelli GM; Figus M; Novielli C; Parisi F; Clementi E; Ferrazzi E; Cetin I
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E404-13. PubMed ID: 24347055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone-Induced Intrauterine Growth Restriction Is Associated With Altered Expressions of Metastasis Tumor Antigens and Cell Cycle Control Proteins in Rat Placentas.
    Alqaryyan M; Kilarkaje N; Mouihate A; Al-Bader MD
    Reprod Sci; 2017 Aug; 24(8):1164-1175. PubMed ID: 27932593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of inflammatory cytokines in placentas from pregnancies complicated with preeclampsia and HELLP syndrome.
    Marusic J; Prusac IK; Tomas SZ; Karara JR; Roje D
    J Matern Fetal Neonatal Med; 2013 May; 26(7):680-5. PubMed ID: 23131093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction.
    Kimura C; Watanabe K; Iwasaki A; Mori T; Matsushita H; Shinohara K; Wakatsuki A
    J Matern Fetal Neonatal Med; 2013 Mar; 26(5):491-6. PubMed ID: 23035823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the blood-group-related antigens Sialyl Lewis a, Sialyl Lewis x and Lewis y in term placentas of normal, preeclampsia, IUGR- and HELLP-complicated pregnancies.
    Minas V; Mylonas I; Schiessl B; Mayr D; Schulze S; Friese K; Jeschke U; Makrigiannakis A
    Histochem Cell Biol; 2007 Jul; 128(1):55-63. PubMed ID: 17551747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique trophoblast stem cell- and pluripotency marker staining patterns depending on gestational age and placenta-associated pregnancy complications.
    Weber M; Göhner C; San Martin S; Vattai A; Hutter S; Parraga M; Jeschke U; Schleussner E; Markert UR; Fitzgerald JS
    Cell Adh Migr; 2016 Mar; 10(1-2):56-65. PubMed ID: 26914354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
    Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
    Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction.
    Acar N; Ustunel I
    Anal Quant Cytopathol Histpathol; 2015 Apr; 37(2):87-95. PubMed ID: 26065228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal gender specific expression of tandem-repeat galectins in placental tissue from normally progressed human pregnancies and intrauterine growth restriction (IUGR).
    Hutter S; Knabl J; Andergassen U; Mayr D; Hofmann S; Kuhn C; Mahner S; Arck P; Jeschke U
    Placenta; 2015 Dec; 36(12):1352-61. PubMed ID: 26462906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas and FasL expression in placentas complicated with intrauterine growth retardation with and without preeclampsia.
    Rešić Karara J; Zekić Tomas S; Marušić J; Roje D; Kuzmić Prusac I
    J Matern Fetal Neonatal Med; 2016; 29(7):1154-9. PubMed ID: 25909501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
    Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
    Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.